WHAT YOU NEED TO KNOW: CAPA Executive Director Matthew Lane Takes Part in R Street Patent Week Panel On June 6, CAPA Executive Director Matthew Lane took part in an R Street panel around Patent Quality Week. The conversation centered around current flaws in the U.S. patent system that enable abuses and results in high drug […]

Continue Reading

WHAT YOU NEED TO KNOW: DID YOU KNOW: Biosimilar Competition Could Reduce Costs for Patients and Drive Accessibility to Lifesaving MedicationsRecently, Inside Health Policy covered a new Cardinal Health report showing as many as 43 biosimilars slated to enter the market will lower U.S drug spending by $133 billion by 2024. Key excerpts: “Cardinal Health analysts predict […]

Continue Reading